Ulipristal Acetate Gedeon Richter European Union - English - EMA (European Medicines Agency)

ulipristal acetate gedeon richter

gedeon richter plc. - ulipristal acetate - leiomyoma - sex hormones and modulators of the genital system, - ulipristal acetate is indicated for one treatment course of pre-operative treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.ulipristal acetate is indicated for intermittent treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age who are not eligible for surgery.

Ganirelix Gedeon Richter European Union - English - EMA (European Medicines Agency)

ganirelix gedeon richter

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - pituitary and hypothalamic hormones and analogues - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

Lenalidomide Gedeon Richter 2.5 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 2.5 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 2.5 mg - immunosuppressants

Lenalidomide Gedeon Richter 5 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 5 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 5 mg - immunosuppressants

Lenalidomide Gedeon Richter 7.5 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 7.5 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 7.5 mg - immunosuppressants

Lenalidomide Gedeon Richter 10 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 10 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 10 mg - immunosuppressants

Lenalidomide Gedeon Richter 15 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 15 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 15 mg - immunosuppressants

Lenalidomide Gedeon Richter 20 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 20 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 20 mg - immunosuppressants

Lenalidomide Gedeon Richter 25 mg hard capsules Malta - English - Medicines Authority

lenalidomide gedeon richter 25 mg hard capsules

gedeon richter plc gyomroi ut 19-21 1103 budapest, hungary - lenalidomide - hard capsule - lenalidomide 25 mg - immunosuppressants

AFOLIA follitropin alfa (rch) 300 IU/0.5 mL (22 microgram) solution for injection cartridge in a pre-filled pen Australia - English - Department of Health (Therapeutic Goods Administration)

afolia follitropin alfa (rch) 300 iu/0.5 ml (22 microgram) solution for injection cartridge in a pre-filled pen

gedeon richter australia pty ltd - follitropin alfa, quantity: 300 iu - injection, solution - excipient ingredients: poloxamer; sucrose; dibasic sodium phosphate dihydrate; monobasic sodium phosphate dihydrate; methionine; phosphoric acid; thymidine; trypsin - in adult women:,- afolia is indicated for the treatment of anovulatory infertility in women who have been unresponsive to clomiphene citrate or where clomiphene citrate is contraindicated,- controlled ovarian hyperstimulation in women undergoing assisted reproductive technologies,- afolia in association with a luteinising hormone (lh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level <1.2 iu/l.,in adult men:,- afolia is indicated with concomitant human chorionic gonadotrophin (hcg) therapy for the stimulation of spermatogenesis in gonadotrophin-deficient men in whom hcg alone is ineffective.